Commentary CRE’s Emerging Drug Problem

You’ve probably heard rumblings about Amazon’s potential entrée into the prescription drug business for the better part of this past year. Yet the latest move by the e-commerce giant has turned that rumor into a reality.

Outbidding Walmart, Amazon just shelled out $1 billion for a startup that will provide it with “nationwide access” to the prescription drug business. The online retailer’s acquisition of PillPack now gives it the ability to ship pharmaceuticals overnight to patients in 49 states.

Read more

Posted Under: CBOR News